Intermittent claudication is a type of muscle pain especially in calf muscle during exercise, such as walking, and is relieved by a short period of rest due to lack of blood supply.
This report contains market size and forecasts of Intermittent Claudication in Global, including the following market information:
Global Intermittent Claudication Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Intermittent Claudication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Treatment Process Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intermittent Claudication include I'ROM GROUP(DNAVEC Corporation), Nuo Therapeutics Inc., Kowa Company Ltd., LTT Bio-Pharma, Pluristem Therapeutics Inc., Nuo Therapeutics, Inc.(Aldagen, Inc.), Genovate Biotechnology Co., Ltd., Novartis AG and ID Pharma Co., Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intermittent Claudication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intermittent Claudication Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Intermittent Claudication Market Segment Percentages, by Type, 2021 (%)
by Treatment Process
Medication Therapies
Revascularization
by Drug Type
ALD-301
DVC1-0101
K-134
LT-0101
PLX-PAD
Tirasemtiv
Global Intermittent Claudication Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Intermittent Claudication Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home Healthcare
Others
Global Intermittent Claudication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Intermittent Claudication Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intermittent Claudication revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Intermittent Claudication revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
I'ROM GROUP(DNAVEC Corporation)
Nuo Therapeutics Inc.
Kowa Company Ltd.
LTT Bio-Pharma
Pluristem Therapeutics Inc.
Nuo Therapeutics, Inc.(Aldagen, Inc.)
Genovate Biotechnology Co., Ltd.
Novartis AG
ID Pharma Co., Ltd
Helixmith Co., Ltd.
G. Pohl-Boskamp GmbH & Co. KG